{
    "clinical_study": {
        "@rank": "38672", 
        "acronym": "PerioBP", 
        "arm_group": [
            {
                "arm_group_label": "Hygenization Treatment", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Basic oral hygiene instructions Supragingival plaque removal"
            }, 
            {
                "arm_group_label": "Intensive Treatment", 
                "arm_group_type": "Experimental", 
                "description": "One-Stage Full-Mouth Disinfection. Scaling and root planing, four quadrants in one session. Extraction of radix relicta.  Subgingival chlorhexidine  (PerioKIN) (0.2%) in all pockets. Oral hygiene instructions."
            }
        ], 
        "brief_summary": {
            "textblock": "Hypertensive patients with chronic periodontitis will be randomized to either intensive\n      treatment or supragingival hygienic treatment and the effects on blood pressure will be\n      identified."
        }, 
        "brief_title": "Study of the Effects of Intensive Treatment of Periodontitis on Blood Pressure Control", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Periodontitis", 
            "Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Periodontitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Periodontitis with three or more periodontal pockets with a probing depth (PD) > 5mm\n\n          -  Bleeding of these periodontal pockets on probing\n\n          -  Have at least 20 natural teeth\n\n          -  Provide informed consent and willingness to cooperate with the study protocol\n\n          -  Age >25 years old\n\n          -  Absence of other significant oral infections.\n\n          -  Primary Hypertension on stable treatment\n\n        Exclusion Criteria:\n\n          -  Clinical symptoms of acute inflammatory disorders incl flu, rhinitis, sinusitis etc.\n             within past 3 weeks\n\n          -  Hospitalization for any reason within the past 3 months; Life expectancy of < 3\n             years;\n\n          -  Allergic disorders; History of chronic infectious disease, Chronic Obstructive\n             Pulmonary Disease (COPD), tuberculosis; chronic hepatitis B or C infection;\n             interstitial pneumonitis, bronchiectasis; known chronic pericardial effusion, pleural\n             effusion, or ascites; liver disease;\n\n          -  Other known chronic inflammatory or autoimmune condition such as lupus or rheumatoid\n             arthritis, ulcerative colitis or Crohn's disease\n\n          -  Secondary hypertension (known plasma renin screening, abdominal ultrasound  with\n             doppler and other investigations)\n\n          -  Non-basal cell malignancy or treated myelo or lymphoproliferative disease within the\n             past 5 years;\n\n          -  Known HIV positive; Immunizations within past 3 months\n\n          -  Individual requires chronic oxygen support or mechanical ventilation  other than\n             nocturnal respiratory support for sleep apnea.\n\n          -  Primary pulmonary hypertension.\n\n          -  Use of systemic or local steroids or immunosuppressive agents within 6 months of the\n             inclusion.\n\n          -  Individual is pregnant or nursing\n\n          -  History of alcohol abuse or unwillingness to limit alcohol consumption to less than 4\n             drinks per week"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131922", 
            "org_study_id": "MOMT-01A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intensive Treatment", 
                "description": "Intensive Surgical Treatment of Periodontitis", 
                "intervention_name": "Intensive Treatment", 
                "intervention_type": "Procedure", 
                "other_name": "Intensive Surgical Treatment of Periodontitis"
            }, 
            {
                "arm_group_label": "Hygenization Treatment", 
                "intervention_name": "Dental Hygienization Treatment", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Intensive Treatment", 
                "description": "Chlorhexidine (PerioKIN) (0.2%) implantation in dental pockets", 
                "intervention_name": "Chlorhexidine (Intensive Treatment)", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chlorhexidine", 
                "Chlorhexidine gluconate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "contact": {
                    "email": "maczesni@yahoo.co.uk", 
                    "last_name": "Marta Czesnikiewicz-Guzik", 
                    "phone": "66683950"
                }, 
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland"
                    }, 
                    "name": "Jagiellonian University Dental Clinic"
                }, 
                "investigator": [
                    {
                        "last_name": "Daniel Nowakowski, DMD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Marta Czesnikiewicz-Guzik, DMD MD PhD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krakow", 
                        "country": "Poland", 
                        "zip": "31-121"
                    }, 
                    "name": "J. Dietl Hospital, Department of Internal and Agricultural Medicine, Jagiellonian University"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Effects of Intensive Treatment of Periodontitis on Blood Pressure Control and Vascular Function", 
        "other_outcome": [
            {
                "measure": "Leukocyte Immunophenotype and Cytokine measurement", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Periodontal Health Score - Probing Depth", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Periodontal Health Score - CAL - Clinical Attachment Loss", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "The Community Periodontal Index of Treatment Needs Index", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Gingival Index", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "overall_contact": {
            "email": "maczesni@yahoo.co.uk", 
            "last_name": "Marta Czesnikiewicz-Guzik, MD PhD", 
            "phone": "66683950"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Poland: Jagiellonian University", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Ambulatory Blood Pressure Monitoring", 
            "measure": "Blood Pressure Change", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131922"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jagiellonian University", 
            "investigator_full_name": "Tomasz Guzik", 
            "investigator_title": "Prof. dr hab. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Vascular Function Measurement", 
            "measure": "Flow Mediated Dilatation", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Jagiellonian University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jagiellonian University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}